TAS::75 0140::TAS Advanced Development of Recombinant Protective Antigent (RPA) Anthrax Vaccine CAN 1990087
Contract Overview
Contract Amount: $92,988,270 ($93.0M)
Contractor: Emergent Product Development Gaithersburg Inc.
Awarding Agency: Department of Health and Human Services
Start Date: 2010-09-17
End Date: 2022-06-09
Contract Duration: 4,283 days
Daily Burn Rate: $21.7K/day
Official Description: TAS::75 0140::TAS ADVANCED DEVELOPMENT OF RECOMBINANT PROTECTIVE ANTIGENT (RPA) ANTHRAX VACCINE CAN 1990087
Place of Performance
Location: Maryland, 20879
State: Maryland Government Spending